Cargando…
Artemisinin Mediates Its Tumor-Suppressive Activity in Hepatocellular Carcinoma Through Targeted Inhibition of FoxM1
The aberrant up-regulation of the oncogenic transcription factor Forkhead box M1 (FoxM1) is associated with tumor development, progression and metastasis in a myriad of carcinomas, thus establishing it as an attractive target for anticancer drug development. FoxM1 overexpression in hepatocellular ca...
Autores principales: | Nandi, Deeptashree, Cheema, Pradeep Singh, Singal, Aakriti, Bharti, Hina, Nag, Alo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652299/ https://www.ncbi.nlm.nih.gov/pubmed/34900697 http://dx.doi.org/10.3389/fonc.2021.751271 |
Ejemplares similares
-
Exploring the therapeutic potential of forkhead box O for outfoxing COVID-19
por: Cheema, Pradeep Singh, et al.
Publicado: (2021) -
Repurposing the Pathogen Box compounds for identification of potent anti-malarials against blood stages of Plasmodium falciparum with PfUCHL3 inhibitory activity
por: Bharti, Hina, et al.
Publicado: (2022) -
Novel functions of FoxM1: from molecular mechanisms to cancer therapy
por: Alvarez-Fernández, Mónica, et al.
Publicado: (2013) -
Avasimibe Dampens Cholangiocarcinoma Progression by Inhibiting FoxM1-AKR1C1 Signaling
por: Gao, Yunshu, et al.
Publicado: (2021) -
FoxM1 Promotes Cell Proliferation, Invasion, and Stem Cell Properties in Nasopharyngeal Carcinoma
por: Luo, Weiren, et al.
Publicado: (2018)